FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2026324518> ?p ?o ?g. }

• W2026324518 endingPage "S64" @default.
• W2026324518 startingPage "S60" @default.
• W2026324518 abstract "Immunosuppressive therapy is the main postoperative treatment for keratoplasty, but there are considerable differences in protocols for the use of steroids and other immunosuppressants. Therefore, we conducted 2 prospective randomized clinical trials and 1 prospective nonrandomized clinical trial on keratoplasty postoperative treatment. One study evaluated the efficacy and safety of long-term topical corticosteroids after a penetrating keratoplasty was performed. Patients who underwent keratoplasty and maintained graft clarity for >1 year were randomly assigned to either a steroid or a no-steroid group. At the 12-month follow-up, the no-steroid group developed significantly more endothelial rejection than did the steroid group. A second study elucidated the effectiveness and safety of systemic cyclosporine in high-risk corneal transplantation. The patients were assigned to a systemic cyclosporine or control group. At a mean follow-up of 42.7 months, no difference was observed in the endothelial rejection rates and graft clarity loss between the 2 groups. A third study elucidated the effectiveness and the safety of systemic tacrolimus in high-risk corneal transplantation. Of 11 consecutive eyes decompensated despite systemic cyclosporine treatment, there was no irreversible rejection in eyes treated with tacrolimus, which was significantly better than in previous penetrating keratoplasty with systemic cyclosporine treatment. Prognosis after keratoplasty in patients with keratoconus is relatively good, but special attention is required for patients with atopic dermatitis. Postkeratoplasty atopic sclerokeratitis (PKAS) is a severe form of sclerokeratitis after keratoplasty in atopic patients. Our retrospective study showed that 35 eyes of 29 patients from a total of 247 keratoconus eyes undergoing keratoplasty were associated with atopic dermatitis, of which 6 eyes of 5 patients developed PKAS. Eyes with PKAS had a significantly higher incidence of atopic blepharitis and preoperative corneal neovascularization, and therefore, we suggest systemic corticosteroids or cyclosporine to prevent PKAS in such high-risk cases." @default.
• W2026324518 created "2016-06-24" @default.
• W2026324518 creator A5023203568 @default.
• W2026324518 creator A5023859247 @default.
• W2026324518 creator A5031999862 @default.
• W2026324518 creator A5051132002 @default.
• W2026324518 creator A5053794454 @default.
• W2026324518 creator A5056200314 @default.
• W2026324518 creator A5062103589 @default.
• W2026324518 date "2013-11-01" @default.
• W2026324518 modified "2023-10-02" @default.
• W2026324518 title "Keratoplasty Postoperative Treatment Update" @default.
• W2026324518 cites W1576161048 @default.
• W2026324518 cites W1828452947 @default.
• W2026324518 cites W1965538727 @default.
• W2026324518 cites W1966375571 @default.
• W2026324518 cites W1971847780 @default.
• W2026324518 cites W1975666195 @default.
• W2026324518 cites W1998099663 @default.
• W2026324518 cites W2003926772 @default.
• W2026324518 cites W2029268528 @default.
• W2026324518 cites W2036862691 @default.
• W2026324518 cites W2058128633 @default.
• W2026324518 cites W2062864844 @default.
• W2026324518 cites W2081678914 @default.
• W2026324518 cites W2081829554 @default.
• W2026324518 cites W2087607363 @default.
• W2026324518 cites W2117184184 @default.
• W2026324518 cites W2131948119 @default.
• W2026324518 cites W2133581019 @default.
• W2026324518 cites W2134468013 @default.
• W2026324518 cites W2144017844 @default.
• W2026324518 cites W2146000776 @default.
• W2026324518 cites W2165177484 @default.
• W2026324518 cites W2210145624 @default.
• W2026324518 cites W2070927872 @default.
• W2026324518 doi "https://doi.org/10.1097/ico.0b013e3182a2c937" @default.
• W2026324518 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24104936" @default.
• W2026324518 hasPublicationYear "2013" @default.
• W2026324518 type Work @default.
• W2026324518 sameAs 2026324518 @default.
• W2026324518 citedByCount "15" @default.
• W2026324518 countsByYear W20263245182014 @default.
• W2026324518 countsByYear W20263245182015 @default.
• W2026324518 countsByYear W20263245182016 @default.
• W2026324518 countsByYear W20263245182017 @default.
• W2026324518 countsByYear W20263245182018 @default.
• W2026324518 countsByYear W20263245182022 @default.
• W2026324518 countsByYear W20263245182023 @default.
• W2026324518 crossrefType "journal-article" @default.
• W2026324518 hasAuthorship W2026324518A5023203568 @default.
• W2026324518 hasAuthorship W2026324518A5023859247 @default.
• W2026324518 hasAuthorship W2026324518A5031999862 @default.
• W2026324518 hasAuthorship W2026324518A5051132002 @default.
• W2026324518 hasAuthorship W2026324518A5053794454 @default.
• W2026324518 hasAuthorship W2026324518A5056200314 @default.
• W2026324518 hasAuthorship W2026324518A5062103589 @default.
• W2026324518 hasConcept C118487528 @default.
• W2026324518 hasConcept C126322002 @default.
• W2026324518 hasConcept C141071460 @default.
• W2026324518 hasConcept C168563851 @default.
• W2026324518 hasConcept C188816634 @default.
• W2026324518 hasConcept C2776882836 @default.
• W2026324518 hasConcept C2777520566 @default.
• W2026324518 hasConcept C2778918178 @default.
• W2026324518 hasConcept C2780686511 @default.
• W2026324518 hasConcept C2909675724 @default.
• W2026324518 hasConcept C2911091166 @default.
• W2026324518 hasConcept C535046627 @default.
• W2026324518 hasConcept C71924100 @default.
• W2026324518 hasConceptScore W2026324518C118487528 @default.
• W2026324518 hasConceptScore W2026324518C126322002 @default.
• W2026324518 hasConceptScore W2026324518C141071460 @default.
• W2026324518 hasConceptScore W2026324518C168563851 @default.
• W2026324518 hasConceptScore W2026324518C188816634 @default.
• W2026324518 hasConceptScore W2026324518C2776882836 @default.
• W2026324518 hasConceptScore W2026324518C2777520566 @default.
• W2026324518 hasConceptScore W2026324518C2778918178 @default.
• W2026324518 hasConceptScore W2026324518C2780686511 @default.
• W2026324518 hasConceptScore W2026324518C2909675724 @default.
• W2026324518 hasConceptScore W2026324518C2911091166 @default.
• W2026324518 hasConceptScore W2026324518C535046627 @default.
• W2026324518 hasConceptScore W2026324518C71924100 @default.
• W2026324518 hasIssue "Supplement 1" @default.
• W2026324518 hasLocation W20263245181 @default.
• W2026324518 hasLocation W20263245182 @default.
• W2026324518 hasOpenAccess W2026324518 @default.
• W2026324518 hasPrimaryLocation W20263245181 @default.
• W2026324518 hasRelatedWork W2026324518 @default.
• W2026324518 hasRelatedWork W2033698628 @default.
• W2026324518 hasRelatedWork W2068331898 @default.
• W2026324518 hasRelatedWork W2074732058 @default.
• W2026324518 hasRelatedWork W2090396765 @default.
• W2026324518 hasRelatedWork W2143925265 @default.
• W2026324518 hasRelatedWork W2369973674 @default.
• W2026324518 hasRelatedWork W2410983929 @default.
• W2026324518 hasRelatedWork W2588179935 @default.
• W2026324518 hasRelatedWork W3095504550 @default.

• next